Respiri Limited is an innovative e-health software-as-a-service (SaaS) company that specializes in the research, development, and commercialization of medical devices. With locations in both Australia and Israel, the company offers a range of mobile health applications, including its flagship product Wheezo. Using Wheezo, users can better understand their asthma by tracking triggers, symptoms, medication usage, and events. Formerly known as iSonea Limited, the company changed its name in 2015 and is based in Melbourne, Australia.